Product Description
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Brazil | Czech | Dominican Republic | Italy | Mexico | Portugal | Slovakia
Approved Indications: None
Known Adverse Events: None
Company: Ache Laboratorios Farmaceuticos S.A.
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Rhinitis|Common Cold|Inflammation
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT01177852 |
ACH-NTS-03(02/10) | P3 |
Withdrawn |
Rhinitis|Inflammation|Common Cold |
2012-04-01 |
2019-03-19 |
Treatments |